TC Biopharm selects Fortrea as contract research organization for global trials

TC BioPharm (TCBP) has selected of Fortrea (FTRE) as the Company’s Contract Research Organization for global trials, including ACHIEVE and ACHIEVE2. The trials, in the UK and US respectively, will be managed by Fortrea on an ongoing basis, creating a vertically integrated clinical trial program which allows for increased operational efficiencies, resulting in better data management and review as well as value creation. TC BioPharm expects to generate cash savings through the creation of these efficiencies by consolidating CRO services under a single entity.